A Study of the Effects of JNJ 26489112 on the Photic Induced Paroxysmal Electroencephalogram Response in Patients With Photosensitive Epilepsy.
Latest Information Update: 31 Mar 2022
At a glance
- Drugs JNJ 26489112 (Primary)
- Indications Epilepsy
- Focus Pharmacodynamics
- 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics
- 04 Jul 2012 Janssen-Cilag added as associations as reported in the European Clinical Trials Database record.
- 27 Aug 2009 Status changed from suspended to completed as reported by ClinicalTrials.gov.